Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

COMMUNITY HEALTH NETWORK, INC

NPI: 1336119478 · INDIANAPOLIS, IN 46219 · General Acute Care Hospital · NPI assigned 01/23/2006

$161.73M
Total Medicaid Paid
2,522,106
Total Claims
1,831,780
Beneficiaries
210
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMILLARD, HOLLY (SVP FINANCE)
NPI Enumeration Date01/23/2006

Related Entities

Other providers sharing the same authorized official: MILLARD, HOLLY

ProviderCityStateTotal Paid
COMMUNITY HEALTH NETWORK, INC INDIANAPOLIS IN $32.97M
COMMUNITY HOSPITAL OF ANDERSON & MADISON COUNTY, INC ANDERSON IN $32.30M
COMMUNITY HOSPITAL SOUTH, INC. INDIANAPOLIS IN $27.35M
FAIRBANKS HOSPITAL, INC. INDIANAPOLIS IN $18.54M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 320,616 $8.74M
2019 319,064 $17.29M
2020 280,028 $19.67M
2021 394,594 $29.62M
2022 509,554 $33.04M
2023 405,485 $30.92M
2024 292,765 $22.47M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 198,739 166,800 $29.53M
99283 Emergency department visit for the evaluation and management, moderate severity 120,049 105,972 $18.09M
90834 Psychotherapy, 45 minutes with patient 122,567 75,964 $14.03M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 171,678 99,978 $11.70M
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 12,159 4,258 $7.53M
71045 Radiologic examination, chest; single view 49,995 41,586 $7.17M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 107,253 82,882 $6.76M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 43,924 35,757 $5.96M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 33,828 14,179 $4.92M
74177 Computed tomography, abdomen and pelvis; with contrast material 12,763 10,289 $4.85M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 91,779 74,487 $3.97M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 35,865 32,662 $3.88M
J9271 Injection, pembrolizumab, 1 mg 664 373 $3.77M
90853 Group psychotherapy (other than of a multiple-family group) 70,656 17,588 $3.53M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 24,610 22,609 $3.16M
96361 Intravenous infusion, hydration; each additional hour 54,725 42,139 $2.18M
90832 Psychotherapy, 30 minutes with patient 15,922 12,571 $1.99M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 26,019 23,170 $1.97M
Q3014 Telehealth originating site facility fee 34,092 20,207 $1.76M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 20,045 7,404 $1.73M
70450 Computed tomography, head or brain; without contrast material 14,101 11,486 $1.62M
90791 Psychiatric diagnostic evaluation 13,524 12,041 $1.48M
71046 Radiologic examination, chest; 2 views 15,300 12,981 $1.29M
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 33,001 23,277 $1.15M
36591 21,034 9,157 $1.07M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 231,379 167,921 $958K
90837 Psychotherapy, 53 minutes with patient 7,403 3,636 $916K
96375 Therapeutic injection; each additional sequential IV push 58,897 38,204 $884K
90839 7,260 6,237 $826K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 11,365 9,593 $804K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 12,166 10,339 $783K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 9,242 8,095 $687K
77067 Screening mammography, bilateral, including computer-aided detection 3,534 3,305 $645K
J0897 Injection, denosumab, 1 mg 546 396 $638K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1,565 1,295 $589K
J1439 Injection, ferric carboxymaltose, 1 mg 771 394 $577K
80048 Basic metabolic panel (calcium, ionized) 107,491 85,220 $516K
71275 Computed tomographic angiography, chest, with contrast material 1,073 882 $479K
84484 68,339 48,107 $472K
90847 Family psychotherapy with the patient present, 50 minutes 8,048 6,183 $467K
80053 Comprehensive metabolic panel 77,459 47,433 $387K
36415 Collection of venous blood by venipuncture 156,233 120,886 $372K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 2,187 725 $335K
90792 Psychiatric diagnostic evaluation with medical services 3,099 2,724 $316K
96417 3,023 1,498 $304K
81025 53,194 45,322 $293K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,039 2,992 $271K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 11,837 10,042 $255K
77336 1,539 514 $206K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,218 1,120 $175K
77063 Screening digital breast tomosynthesis, bilateral 3,199 2,983 $164K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,478 1,581 $160K
87086 Culture, bacterial; quantitative colony count, urine 32,398 26,470 $151K
83690 37,799 30,706 $130K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 3,231 2,968 $128K
99217 363 246 $119K
77386 134 13 $118K
99218 334 228 $108K
81001 54,514 44,685 $106K
99221 273 199 $103K
J2469 Injection, palonosetron hcl, 25 mcg 3,591 1,552 $101K
80076 19,823 15,994 $100K
99215 Prolong outpt/office vis 773 707 $99K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,600 2,391 $95K
99239 Hospital discharge day management, more than 30 minutes 319 231 $95K
87088 19,291 15,842 $90K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 767 682 $85K
97161 793 681 $80K
80047 17,108 13,651 $72K
82728 9,691 7,717 $72K
78815 Positron emission tomography (PET) for limited area imaging 47 37 $68K
J0185 Injection, aprepitant, 1 mg 325 159 $67K
80050 General health panel 368 286 $63K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,666 1,436 $59K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 247 215 $55K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 91 61 $53K
77412 172 12 $50K
77334 221 119 $44K
83550 8,901 7,131 $43K
G0378 Hospital observation service, per hour 730 265 $39K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 31,850 12,475 $38K
74176 Computed tomography, abdomen and pelvis; without contrast material 206 134 $36K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,994 2,242 $35K
83540 8,926 7,150 $32K
83880 1,624 1,253 $32K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 604 505 $32K
90846 Family psychotherapy without the patient present, 50 minutes 499 330 $31K
93017 208 168 $30K
J1950 Injection, leuprolide acetate (for depot suspension), per 3.75 mg 28 25 $28K
76642 212 185 $25K
96415 368 164 $24K
95811 14 14 $23K
99231 Subsequent hospital care, per day, straightforward or low complexity 96 40 $22K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,037 865 $22K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 988 825 $21K
87634 308 283 $18K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 43 40 $17K
84443 Thyroid stimulating hormone (TSH) 2,718 1,436 $14K
77300 77 62 $13K
84439 3,385 1,868 $13K
36592 615 343 $12K
72170 447 360 $12K
82607 1,382 1,050 $11K
83520 780 591 $11K
82746 1,253 945 $10K
86334 1,156 798 $9K
82784 856 632 $9K
96416 48 25 $9K
85014 6,930 5,509 $9K
73564 241 107 $9K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 709 623 $7K
99234 16 13 $7K
97597 93 52 $7K
20610 73 42 $7K
82553 4,405 2,478 $7K
72100 163 141 $7K
96402 795 587 $6K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 151 126 $6K
77065 Tomosynthesis, mammo 45 38 $6K
83735 1,737 725 $5K
80305 467 362 $5K
11045 29 12 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 567 261 $5K
85379 648 535 $4K
96367 251 101 $4K
84165 1,806 1,290 $4K
74018 36 28 $4K
71260 Computed tomography, thorax, diagnostic; with contrast material 23 13 $4K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 765 208 $3K
81003 2,519 2,146 $3K
77066 Tomosynthesis, mammo 14 13 $3K
71250 14 14 $3K
76830 Ultrasound, transvaginal 15 13 $3K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 15 15 $3K
94799 185 79 $3K
85027 809 593 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 15 13 $2K
84100 1,402 882 $2K
83883 246 173 $2K
87081 453 401 $2K
87808 197 168 $2K
82565 567 393 $2K
T1015 Clinic visit/encounter, all-inclusive 78 76 $2K
96376 697 416 $2K
29581 21 12 $2K
J1756 Injection, iron sucrose, 1 mg 30 12 $1K
94760 44 12 $1K
J1631 Injection, haloperidol decanoate, per 50 mg 281 194 $1K
83521 108 57 $1K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 12 12 $1K
J9190 Injection, fluorouracil, 500 mg 157 37 $1K
J2785 Injection, regadenoson, 0.1 mg 29 27 $891.40
82947 161 72 $776.60
94060 13 12 $765.32
73562 20 16 $747.58
87905 80 66 $745.43
72125 Computed tomography, cervical spine; without contrast material 15 12 $594.00
82657 62 54 $560.08
83921 78 56 $555.16
82077 45 42 $536.00
87077 110 88 $531.52
82962 241 107 $497.83
73610 19 13 $478.03
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 232 162 $476.28
82378 52 39 $448.41
94761 37 13 $392.80
87641 12 12 $315.81
94726 13 12 $283.68
83605 36 27 $254.28
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 15 14 $244.89
83090 23 15 $207.88
84132 65 59 $190.96
80306 29 26 $185.30
81002 148 105 $176.26
J1885 Injection, ketorolac tromethamine, per 15 mg 9,586 7,444 $174.20
85610 49 38 $154.39
84295 51 47 $141.08
85018 158 87 $127.61
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 1,732 1,406 $123.86
84155 101 64 $113.10
82948 46 12 $84.98
84702 12 12 $83.56
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,727 632 $83.17
82435 30 27 $81.12
87186 16 13 $75.59
84520 30 27 $69.66
73130 46 39 $45.93
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 75 55 $37.28
83615 12 12 $26.04
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 14 12 $25.81
85378 15 12 $18.84
J0401 Injection, aripiprazole (abilify maintena), 1 mg 74 25 $4.97
J2405 Injection, ondansetron hydrochloride, per 1 mg 5,139 3,894 $2.40
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 292 238 $0.00
J0640 Injection, leucovorin calcium, per 50 mg 102 37 $0.00
J2426 Injection, paliperidone palmitate extended release (invega sustenna), 1 mg 132 44 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 30 26 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 302 203 $0.00
J1750 Injection, iron dextran, 50 mg 50 13 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 120 37 $0.00
72110 17 12 $0.00
77387 164 12 $0.00
J3370 Injection, vancomycin hcl, 500 mg 36 25 $0.00
94729 13 12 $0.00
88305 Level IV - Surgical pathology, gross and microscopic examination 13 12 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 274 219 $0.00
J0690 Injection, cefazolin sodium, 500 mg 43 12 $0.00
J2704 Injection, propofol, 10 mg 44 26 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 14 14 $0.00
G0008 Administration of influenza virus vaccine 15 13 $0.00